<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=curropininvestigdrugs&amp;quantity=&amp;format=rss&amp;version=">
        <title>Current Opinion in Investigational Drugs - Latest Articles</title>
        <link>http://www.biomedcentral.com/curropininvestigdrugs/</link>
        <description>The latest research articles published by Current Opinion in Investigational Drugs</description>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="">
        <title>Subject Index - Volume 10</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1402</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1402</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Antiangiogenic therapies in breast cancer</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1334</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1334</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Combination chemotherapy for head and neck cancer: The addition of Bcl-2 inhibitors</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1325</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1325</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>GM-CSF-secreting vaccines for solid tumors</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1315</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1315</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancer</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1305</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1305</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Phosphatases as targets for cancer treatment</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1297</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1297</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Microbial antitumor drugs: Natural products of microbial origin as anticancer agents</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1280</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1280</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Autophagy inhibition in combination cancer treatment</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1269</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1269</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Kinase inhibitor selectivity</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1266</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1266</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Paper alert</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Investigational Drugs 2009, 10:1251</dc:source>
        <dc:date>2009-11-20T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Investigational Drugs</prism:publicationName>
        <prism:issn>1472-4472</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>1251</prism:startingPage>
        <prism:publicationDate>2009-11-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
